Stoke Therapeutics Inc (NAS:STOK)
$ 13.9 -0.13 (-0.93%) Market Cap: 724.47 Mil Enterprise Value: 548.10 Mil PE Ratio: 0 PB Ratio: 4.61 GF Score: 38/100

Stoke Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 13, 2023 / 01:00PM GMT
Release Date Price: $12.46 (+3.06%)
Edward Kaye
Stoke Therapeutics, Inc. - CEO & Director

Good morning, ladies and gentlemen. I am Edward Kay, Chief Executive Officer of Stoke Therapeutics. It's a pleasure to welcome you to our annual meeting of stockholders. Thank you for joining us today. We're excited to be hosting our virtual annual meeting, which allows us to be more inclusive to reiterate the numbers of stockholders.

We have stockholders attending via the web portal and the 800 number that we have provided. We will conduct the business portion of our meeting first and answer questions at the end of the meeting. Though we may not be able to answer every question, we will do our best to provide a response to as many as possible.

In keeping with the digital approach to this year's meeting, it is now 09:00 Eastern Time on June 13, 2023, and the meeting is officially called to order.

I now would like to introduce the following members of the Board of Directors who are with us this morning: myself, Edward Kaye; Jennifer Burstein; Dr. Adrian Krainer; and Dr. Arthur Tzianabos. I would also like to introduce

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot